Health Care Distributors

Cardinal Health (NYSE: CAH) reports its Q2 EPS at $0.61, versus the consensus of $0.61. CAH reports its Q2 revenue at $25.37 billion, versus the consensus of $25.12 billion. CAH shares fell 0.19% to $41.61 in after-hours trading. Read more from Benzinga's Company news.

Cardinal Health (CAH) is slated to report second-quarter fiscal 2011 (ending December 31) results on Thursday, February 3. The current Zacks Consensus Estimate for the second quarter is 61 cents per share, representing an estimated 7.20% year-over-year hike. The company expects earnings per share...

Cardinal Health (CAH) is slated to report second-quarter fiscal 2011 (ending December 31) results on Thursday, February 3. The current Zacks Consensus Estimate for the second quarter is 61 cents per share, representing an estimated 7.20% year-over-year hike. The company expects earnings per share...

Cusick's Corner This is Frosty the Joe Man reporting on “Snowmageddon 2011” and being the contrarian -- I am a seller of firewood. With that said, this may actually be the worst snowstorm in Chicago since ‘67 & ‘99 but I digress from a hot market. Right now we are at levels that we have not...

McKesson Corp.'s (MCK) third quarter fiscal 2011 earnings of $1.22 per share (excluding special items) beat the Zacks Consensus Estimate by 11 cents and the year-ago earnings by 3 cents. Including expenses associated with the acquisition of US Oncology, earnings for the quarter came in at $1.12...

McKesson Corp.'s (MCK) third quarter fiscal 2011 earnings of $1.22 per share (excluding special items) beat the Zacks Consensus Estimate by 11 cents and the year-ago earnings by 3 cents. Including expenses associated with the acquisition of US Oncology, earnings for the quarter came in at $1.12...

Shares of McKesson Corporation (NYSE: MCK) are higher on the session by 2.61%, trading at $77.13. Overall call volume is now running at 4.21x the daily average, with 6% of all calls traded being purchases on the offer. 4,777 contracts have traded on the session so far. McKesson Corporation...

Goldman Sachs is out with its report on McKesson (NYSE: MCK), raising its price target from $84 to $87 due to "solid core business performance." In a note to clients, Goldman Sachs writes, "McKesson reported 3QFY11 EPS of $1.22 (excluding one-time items), which was above our/consensus estimate of...

• ExxonMobil (NYSE:XOM) reported Q4 EPS of $1.85, ahead of the Zacks Consensus Estimate of $1.68 per share. Revenues for the quarter rose to $105.2 billion, lower than the Zacks Consensus Estimate of $113.268 billion • Alpha Natural Resources (NYSE:ANR) announced a plan to acquire fellow...

• ExxonMobil (NYSE:XOM) reported Q4 EPS of $1.85, ahead of the Zacks Consensus Estimate of $1.68 per share. Revenues for the quarter rose to $105.2 billion, lower than the Zacks Consensus Estimate of $113.268 billion • Alpha Natural Resources (NYSE:ANR) announced a plan to acquire fellow...

J.P. Morgan is out with its report today on McKesson (NYSE: MCK), raising its price target from $87 to $93. In a note to clients, J.P. Morgan writes, "We are raising our target price to $93 and FY11 EPS to $4.94 from our previous estimate of $4.75, primarily due to the strong results seen this...

Goldman Sachs has raised the price target on McKesson Corporation (NYSE: MCK) from $84 to $87 and maintains its Buy rating.

JP Morgan has raised the price target on McKesson Corporation (NYSE: MCK) from $87 to $93 and maintains its Overweight rating.

McKesson Corporation (NYSE: MCK) today reported that revenues for the third quarter ended December 31, 2010 were $28.2 billion. Third-quarter earnings per diluted share was 60 cents, which included a pre-tax Average Wholesale Price litigation charge of $189 million ($133 million after-tax or 52...